Report cover image

Clinical Trials - The Movement Towards Decentralized Clinical Trials

Publisher GlobalData
Published Oct 10, 2022
Length 31 Pages
SKU # GBDT17493355

Description

Clinical Trials - The Movement Towards Decentralized Clinical Trials

Summary

This report provides an analysis on DCT's/Virtual trials.

Key Highlights
  • DCT usage is on the rise
  • North America has conducted the most DCTs
  • Mobile Healthcare is the top virtual component used
Scope
  • The clinical trial data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The report focuses on DCT trials that were initiated between 2001 to 2022.
  • The data have been analyzed by year, phase, status, therapy area, indication, geography, sponsor type (top industry sponsors versus non-industry sponsors), and reasons for discontinuation. In this report, a small number of Phase 0, Phase I/II, Phase II/III, and Phase III/IV trials were combined with Phase I, Phase II, Phase III, and Phase IV trials, respectively.
Reasons to Buy
  • Provides a breakdown of DCT's across a number of clinical trial sectors.
  • Identifies which areas are using DCT's the most.
  • Highlights the use of DCT's in the industry and against institutional sponsors.

Table of Contents

31 Pages
Executive Summary
Introduction
Report Scope
Methodology
Clinical Trials Landscape of Real-World Evidence Trials
2022 Projected to Be a Leading Year for DCTs
The Largest Proportion of DCTs Are in Phase II
Mobile Healthcare Is a Key Virtual Trial Component for DCTs
North America Leads for DCTs
North America Dominates for All Virtual Components
North America leads Single-Country DCTs, Followed by Europe and Asia-Pacific
US Leads DCT Usage
Central Nervous System Is the Most Researched Therapy Area for DCTs
Type 2 Diabetes Is the Most Researched Indication for DCTs
Low Accrual Rate Is the Leading Cause of Trial Termination
More Industry Trials Achieve Their Endpoints
GSK Is the Top Industry Sponsor for DCTs
Duke University Is the Top Non-Industry Sponsor for DCTs
Key Findings
Appendix
List of Figures
Figure 1: Number of DCTs by sponsor type and year
Figure 2: DCTs by phase and status
Figure 3: Virtual trial components by status
Figure 4: DCTs by regional distribution
Figure 5: Virtual components by region
Figure 6: Single-country and multinational DCTs by region
Figure 7: Distribution of DCTs by top five countries
Figure 8: DCTs by therapy area
Figure 9: DCTs by indication
Figure 10: Reasons for trial discontinuation of DCTs
Figure 11: Completed trials endpoint status, by sponsor type
Figure 12: Top industry sponsors for DCTs
Figure 13: Top non-industry sponsors for DCTs
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.